Literature DB >> 17325835

The European Society of Intensive Care Medicine (ESICM) and the Surviving Sepsis Campaign (SSC).

V Marco Ranieri1, Rui P Moreno, Andy Rhodes.   

Abstract

Mesh：

Year:  2007        PMID： 17325835     DOI： 10.1007/s00134-007-0572-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  12 in total

1.  Impact of randomized trial results on acute lung injury ventilator therapy in teaching hospitals.

Authors:  Craig R Weinert; Cynthia R Gross; William A Marinelli
Journal:  Am J Respir Crit Care Med       Date:  2003-02-05       Impact factor: 21.405

2.  The surviving sepsis guidelines: "lost in translation".

Authors:  Dante Landucci
Journal:  Crit Care Med       Date:  2004-07       Impact factor: 7.598

3.  A blind clinical evaluation committee should, in theory, make data of a randomized clinical trial stronger, not weaker.

Authors:  J Carlet
Journal:  Intensive Care Med       Date:  2004-04-09       Impact factor: 17.440

4.  Activated protein C: do more survive?

Authors:  Alasdair F Mackenzie
Journal:  Intensive Care Med       Date:  2005-10-15       Impact factor: 17.440

5.  Bioethics, the Surviving Sepsis Campaign, and the industry.

Authors:  Christian J Wiedermann
Journal:  Wien Klin Wochenschr       Date:  2005-07       Impact factor: 1.704

6.  When a single pivotal trial should not be enough-the case of drotrecogin-alfa (activated).

Authors:  Christian J Wiedermann
Journal:  Intensive Care Med       Date:  2006-03-01       Impact factor: 17.440

7.  Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly.

Authors:  Peter Q Eichacker; Charles Natanson; Robert L Danner
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

8.  Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial.

Authors:  Jean-François Dhainaut; Pierre-François Laterre; Jonathan M Janes; Gordon R Bernard; Antonio Artigas; Jan Bakker; Hanno Riess; Bruce R Basson; Julien Charpentier; Barbara G Utterback; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2003-04-24       Impact factor: 17.440

9.  Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study.

Authors:  Christian Brun-Buisson; Cosetta Minelli; Guido Bertolini; Luca Brazzi; Jorge Pimentel; Klaus Lewandowski; Julian Bion; Jacques-André Romand; Jesús Villar; Adalbjörn Thorsteinsson; Pierre Damas; Apostolos Armaganidis; François Lemaire
Journal:  Intensive Care Med       Date:  2003-10-16       Impact factor: 17.440

10.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Authors:  R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; M M Levy
Journal:  Intensive Care Med       Date:  2004-03-03       Impact factor: 17.440
View more
  2 in total

1.  The Surviving Sepsis Campaign: robust evaluation and high-quality primary research is still needed.

Authors:  Simon Finfer
Journal:  Intensive Care Med       Date:  2010-01-13       Impact factor: 17.440

2.  Editors' comments on a new trial of activated protein C for persistent septic shock.

Authors:  Jordi Mancebo; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2008-10-07       Impact factor: 17.440
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.